Extrait
The purpose of this study is to characterize the pharmacokinetics (blood levels) of trabectedin after administration to patients with advanced malignancies and hepatic (liver) dysfunction.
Critère d'inclusion
- Neoplasm Metastases ,Hepatic Insufficiency